WINNIPEG, MANITOBA--(Marketwire - September 23, 2008) - Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests for unmet clinical needs, announces that the Board of Directors has granted 500,000 options at an exercise price of $0.15 per share to Mr. Christopher Moreau, President and CEO, in accordance with the Company’s stock option plan. The options are subject to regulatory approval.
